Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies
lungcanc
From Patient to Patient Research Advocate: The STARS Journey
lungcanc
Letter to the Editor: Patient-Driven Research
lungcanc
Highlights From the 2019 IASLC Latin American Conference in Lung Cancer
lungcanc
Dr. Richard Pazdur Discusses Project Facilitate and the Expanded-Access Program
lungcanc
IASLC 2019 World Conference on Lung Cancer: Collaborative Formats, Novel Data
lungcanc
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
lungcanc
Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data
lungcanc
Jeffrey Bradley, MD, FASTRO
lungcanc
Vassiliki Papadimitrakopoulou, MD
lungcanc
1
...
11
12
13
...
53
Page 12 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
